Lipoprotein Lipase Antikörper (C-Term)

Produktnummer ABIN1108052

Produktdetails anti-Lipoprotein Lipase Antikörper

Target: Lipoprotein Lipase (LPL)

Bindungsspezifität: C-Term

Reaktivität: Human, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Lipoprotein Lipase Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: This antibody detects Lipoprotein lipase (C-term). No cross reactivity with other proteins.

Kreuzreaktivität (Details): Species reactivity (tested):Human, rat, mouse, bovine

Aufreinigung: Immunogen affinity purified

Immunogen: A synthetic peptide corresponding to a sequence at the C-terminal of human LPL .Remarks: Sequence is different to the related rat sequence by two amino acids.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Rekonstitution: 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

Buffer: 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg NaN3

Konservierungsmittel: Sodium azide, Thimerosal (Merthiolate)

Vorsichtsmaßnahmen: This product contains Sodium azide and Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.

Details zu Lipoprotein Lipase

Target: Lipoprotein Lipase (LPL)

Andere Bezeichnung: Lipoprotein Lipase (LPL Produkte)

Synonyme: HDLCQ11 antikoerper, LIPD antikoerper, fb62e04 antikoerper, fc49b03 antikoerper, wu:fb62e04 antikoerper, wu:fc49b03 antikoerper, LPL antikoerper, lipd antikoerper, hdlcq11 antikoerper, lpl antikoerper, LOC100223817 antikoerper, lipoprotein lipase antikoerper, LPL antikoerper, Lpl antikoerper, lpl antikoerper

Hintergrund: Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. Lipoprotein lipase has been difficult to purify, and its protein sequence remained undetermined until it could be deduced from the nucleotide sequence of its cDNA. The gene encodes a protein of 475 amino acids that becomes a mature protein of 448 residues after cleavage of a signal peptide. Analysis of the sequence indicated that human lipoprotein lipase, hepatic lipase, and pancreatic lipase are members of a gene family. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion.Synonyms: EC=3.1.1.34, LIPD, LPL

Gen-ID: 280843

NCBI Accession: NP_001068588

UniProt: P11151

Pathways: Lipid Metabolism